1. Home
  2. DNUT vs NVCR Comparison

DNUT vs NVCR Comparison

Compare DNUT & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.01

Market Cap

577.8M

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$16.48

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
NVCR
Founded
1937
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Food Chains
Medical/Dental Instruments
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
577.8M
2.0B
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
DNUT
NVCR
Price
$3.01
$16.48
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$4.15
$28.08
AVG Volume (30 Days)
1.9M
945.5K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
$1,522,616,000.00
$655,353,000.00
Revenue This Year
$0.55
$7.72
Revenue Next Year
$3.59
$6.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.28
52 Week Low
$2.88
$9.82
52 Week High
$5.11
$21.45

Technical Indicators

Market Signals
Indicator
DNUT
NVCR
Relative Strength Index (RSI) 33.80 48.03
Support Level $2.88 $16.33
Resistance Level $3.72 $18.43
Average True Range (ATR) 0.11 0.75
MACD -0.04 -0.05
Stochastic Oscillator 7.27 41.12

Price Performance

Historical Comparison
DNUT
NVCR

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: